About Start Madrid-FJD, Fundación Jimѐnez Díaz
El Hospital Universitario Fundación Jiménez Díaz es un centro médico privado con concierto público situado en Madrid perteneciente al Grupo Quirónsalud. Fue inaugurado el 1 de julio de 1955 por el médico Carlos Jiménez Díaz como «Clínica de la Concepción», de gestión público-privada.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Adaptimmune
2
Clinical Trials at Start Madrid-FJD, Fundación Jimѐnez Díaz
During the past decade, Start Madrid-FJD, Fundación Jimѐnez Díaz conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
2016-10-01
2020-06-04
Completed
10
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
2019-08-13
2034-11-01
Recruiting
90
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Start Madrid-FJD, Fundación Jimѐnez Díaz
According to Clinical.Site data, the most researched conditions in "Start Madrid-FJD, Fundación Jimѐnez Díaz" are
"Bladder Urothelial Carcinoma" (1 trials), "Head and Neck Cancer" (1 trials), "Melanoma" (1 trials), "Myxoid Liposarcoma" (1 trials) and "Synovial Sarcoma" (1 trials). Many other conditions were trialed in "Start Madrid-FJD, Fundación Jimѐnez Díaz" in a lesser frequency.
Clinical Trials Intervention Types at Start Madrid-FJD, Fundación Jimѐnez Díaz
Most popular intervention types in "Start Madrid-FJD, Fundación Jimѐnez Díaz" are "Genetic" (2 trials). Other intervention types were less common.
The name of intervention was led by "Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells" (1 trials) and "afamitresgene autoleucel (previously ADP-A2M4)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Start Madrid-FJD, Fundación Jimѐnez Díaz
The vast majority of trials in "Start Madrid-FJD, Fundación Jimѐnez Díaz" are
2 trials for "All" genders.
Clinical Trials Status at Start Madrid-FJD, Fundación Jimѐnez Díaz
Currently, there are NaN active trials in "Start Madrid-FJD, Fundación Jimѐnez Díaz".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Start Madrid-FJD, Fundación Jimѐnez Díaz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Start Madrid-FJD, Fundación Jimѐnez Díaz, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".